Offer - Urjas Oil for just ₹ 1 X
Rozustat F Tablet, a prescription drug, is manufactured in various forms such as Tablet. Rozustat F Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Rozustat F Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The most common side effects of Rozustat F Tablet are Nausea or vomiting, Headache, Constipation. Besides the aforementioned side effects, there are other adverse effects of Rozustat F Tablet as well, which are listed below. Usually, these side effects of Rozustat F Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Rozustat F Tablet's effect during pregnancy is Moderate and Moderate while nursing. It is important to know if Rozustat F Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rozustat F Tablet related warnings section.
Rozustat F Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rozustat F Tablet in conditions like Diabetes.
Besides this, Rozustat F Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Rozustat F Tablet is not safe while driving, and is not addiction.
Rozustat F Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rozustat F Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Rozustat F. It is best to stop taking Rozustat F immediately and inform your doctor if you notice any discomfort.
Is the use of Rozustat F Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Rozustat F. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Rozustat F Tablet on the Kidneys?
Rozustat F rarely affects the kidneys.
What is the effect of Rozustat F Tablet on the Liver?
Rozustat F is rarely harmful for the liver.
What is the effect of Rozustat F Tablet on the Heart?
The heart can be affected by Rozustat F. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Rozustat F Tablet unless your doctor advises you to do so -
Is this Rozustat F Tablet habit forming or addictive?
No, there is no any evidence that Rozustat F Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rozustat F Tablet, you should not drive or work on any heavy machine, as Rozustat F Tablet can make you drowsy.
Is it safe?
Rozustat F Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Rozustat F Tablet in mental disorders is not effective.
Interaction between Food and Rozustat F Tablet
Due to the absence of research, it is difficult to say how Rozustat F Tablet and food will interact.
Interaction between Alcohol and Rozustat F Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Rozustat F Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650